Search for Tradename: LESCOL

Summary for Tradename: LESCOL

Patents:	3
Applicants:	1
NDAs:	2
Therapeutic Class:	Cardiovascular Agents

Glossary

Applicant	Tradename	Generic Name	NDA	Approval Date	Type	RLD	Patent Number	Delist Req.	Patent Expiration	Exclusivity Expiration
Novartis	LESCOL	fluvastatin sodium	020261	Dec 31, 1993	RX	No				Oct 10, 2009
Novartis	LESCOL	fluvastatin sodium	020261	Dec 31, 1993	RX	No	5,354,772*PED	Y	Apr 11, 2012
Novartis	LESCOL	fluvastatin sodium	020261	Dec 31, 1993	RX	No	5,356,896*PED	Y	Jun 12, 2012

Export available with Ultimate Plan subscription:

This preview shows a limited data set. Complete access is available with a Subscription

Paragraph IV activity for: LESCOL

Drugname	Dosage	Strength	RLD	Submissiondate
fluvastatin	Capsules	20 mg and 40 mg	Lescol	6/4/2008
fluvastatin sodium	Extended-release Tablets	80 mg	Lescol XL	3/15/2007

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:
2000 2001 2002 2003 2004
2005 2006 2007 2008 2009

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Follow DrugPatentWatch on Twitter

Bookmark or Share This Page ...

Search for Tradename: LESCOL

Summary for Tradename: LESCOL

Glossary

Paragraph IV activity for: LESCOL

<- Back to Dashboard

DrugPatentWatch Archives